Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Annette Alaeus"'
Autor:
Helena Skar, Ryan N Gutenkunst, Karin Wilbe Ramsay, Annette Alaeus, Jan Albert, Thomas Leitner
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e21747 (2011)
The molecular evolution of HIV-1 is characterized by frequent substitutions, indels and recombination events. In addition, a HIV-1 population may adapt through frequency changes of its variants. To reveal such population dynamics we analyzed HIV-1 su
Externí odkaz:
https://doaj.org/article/84aa7ac48de946049c1b8fb5ec7d845f
Autor:
Nina Weis, Annette Alaeus, Galia Askarieh, Karolin Falconer, Kristoffer Hellstrand, Martin Lagging
Publikováno v:
Scandinavian Journal of Infectious Diseases. 42:896-901
The aim of this study was to investigate the utility of baseline plasma interferon-gamma inducible protein-10 (IP-10) levels in human immunodeficiency virus (HIV)–hepatitis C virus (HCV) co-infected patients. Baseline IP-10 was monitored during HCV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17fc046d4974e8708c3c0bcc52177e08
https://doi.org/10.3109/00365548.2010.498019
https://doi.org/10.3109/00365548.2010.498019
Autor:
Johan K. Sandberg, Karolin Falconer, Ola Weiland, Kim Blom, Veronica D. Gonzalez, Hans-Gustaf Ljunggren, Niklas K. Björkström, Annette Alaeus
Publikováno v:
The Journal of Immunology. 183:6612-6618
NK cells are important innate immune effector cells, normally characterized as CD56+CD3− lymphocytes. In this study, we report that CD56−CD16+ NK cells expand in many patients with chronic hepatitis C virus infection. These CD56− NK cells were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd518ea95e07c582065cfa59eaf4eb6
https://doi.org/10.4049/jimmunol.0901437
https://doi.org/10.4049/jimmunol.0901437
Autor:
Veronica D. Gonzalez, Alex Lund Laursen, Karolin Falconer, Nina Weis, Johan K. Sandberg, Annette Alaeus, Kim Blom, Birgitte Mørn, Olle Reichard
Publikováno v:
BASE-Bielefeld Academic Search Engine
Chronic immune activation is a driver of human immunodeficiency virus type 1 (HIV-1) disease progression. Here, we describe that subjects with chronic hepatitis C virus (HCV)/HIV-1 coinfection display sharply elevated immune activation as determined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd7aceb0b1c29eac84c07b2e7647feae
https://doi.org/10.1128/jvi.01211-09
https://doi.org/10.1128/jvi.01211-09
Publikováno v:
Scandinavian Journal of Infectious Diseases. :1-5
We investigated the prevalence of hepatitis C virus (HCV) co-infection in HIV-infected patients at a large Swedish outpatient clinic. We also evaluated the feasibility of treating this patient group with pegylated-interferon alpha-2a and ribavirin (R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86ff39ea269f0471bbeb30ffc05a6e46
https://doi.org/10.1080/00365540903214272
https://doi.org/10.1080/00365540903214272
Autor:
Ann-Charlotte Boström, Britta Wahren, Lindvi Gudmundsdotter, Rebecca Theve-Palm, Anna Sjödin, Knut Lidman, Bo Hejdeman, Annette Alaeus
Publikováno v:
Springer Seminars in Immunopathology. 28:221-230
Vaccines have entered into human clinical trials against infectious diseases and as therapies against cancer. The HIV virus establishes a latent infection at a very early stage and the T cell memory of the infected patient is rapidly destroyed. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c94cc7cab48b0958185c6ade5376c703
https://doi.org/10.1007/s00281-006-0029-0
https://doi.org/10.1007/s00281-006-0029-0
Publikováno v:
AIDS Research and Human Retroviruses. 21:221-227
The objective of this study was to investigate the short-term virological outcome of antiretroviral combination therapy (ART) in relation to infection with different HIV-1 genetic subtypes. Antiretroviral drug-naive patients in Sweden were prospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c05920ced9c4c6eeb95c408045f24c6
https://doi.org/10.1089/aid.2005.21.221
https://doi.org/10.1089/aid.2005.21.221
Autor:
Annette Alaeus, Angelo De Milito, Anna Nilsson, Tran Thi Thanh Ha, Ann Atlas, Francesca Chiodi, Anna Lindström
Publikováno v:
Journal of Medical Virology. 72:345-351
HIV-1 genetic subtypes might have a different impact on disease progression and response to antiretroviral therapy (ART). Few data are available on the immune activation profile in patients with different HIV-1 subtypes. We have tested by ELISA the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c6cead89909afa9e7890b958aa02a86
https://doi.org/10.1002/jmv.20006
https://doi.org/10.1002/jmv.20006
Publikováno v:
AIDS Research and Human Retroviruses. 19:989-997
The prevalence of genetic drug resistance in newly diagnosed HIV-1 cases and potential subtype-specific mutation patterns were studied. Samples from 100 newly diagnosed patients were randomly chosen from three HIV clinics in Sweden, prospectively col
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0185664c4af0d2d5adada48b327b4eba
https://doi.org/10.1089/088922203322588341
https://doi.org/10.1089/088922203322588341
Autor:
Eric Sanders-Buell, Mika Salminen, Jean K. Carr, Francine E. McCutchan, Bohye Kim, Deborah L. Birx, Tiina Laukkanen, Annette Alaeus, Jan Albert
Publikováno v:
AIDS. 13:1819-1826
The objective was to improve our understanding of the genetic complexity of HIV-1 subtype A by increasing the number of subtype A isolates that have been sequenced in their entirety. Nine HIV- 1-seropositive patients from Africa living in Sweden cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f41e84b451812f19512a6b140034a9a2
https://doi.org/10.1097/00002030-199910010-00003
https://doi.org/10.1097/00002030-199910010-00003